期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

基质金属蛋白酶及其抑制物在正常和异位子宫内膜中的表达 被引量：2

The expression of matrix metalloproteinase and its inhibitor in eutopic and ectopic endometria
下载PDF
导出
摘要 目的研究基质金属蛋白酶2、9（Matrix metalloprotein MMP2、MMP9）和基质金属蛋白酶抑制剂1（TIMP1）与子宫内膜异位症的相关性.方法采用免疫组化方法检测MMP2、MMP9、TIMP1蛋白的表达.结果 异位子宫内膜标本中MMP2表达增强,MMP9、TIMP1的表达在各组之间差异无统计学意义.结论 MMP2可能与子宫内膜异位症的发生密切相关. Objective To evahtate the expression and localization of matrix metalloproteinase2,9 （MMP2, MMP9）and tissue inhibitor of matrix metollaproteinase 1 （ TIMP1 ） in endometriosis. Method The expression of MMP2, MMP9 protein on paraffin - embeded tissues was determined by immunohistochemical analysis. Results Endometriotic tissues showed statisticaly stronger MMP2 protein compared with eutopie endometfia （P 〈0.05 ）. MMP9 ,TIMP1 expresion were same in eutopic endometria and ectopic endometria. Conclusion Compared to eutopie endometrium, ectopic endometrium has a higher capacity to produce MMP2.
作者 王丽 李东爽 郭雪霏
机构地区 解放军
出处 《浙江临床医学》 2011年第4期364-365,共2页 Zhejiang Clinical Medical Journal
关键词 子宫内膜异位症 基质金属蛋白酶2、9 基质金属蛋白酶抑制剂 Endometriosis matrix Metalloproteinase 2,9 Matrix metollaproteinase
分类号 R587.2 [医药卫生—内分泌]
  • 相关文献

参考文献10

  • 1丰有吉编.妇产科学.北京:人民卫生出版社,2004.358.
  • 2Fernadez-Shaw S,Marshall JM,Hicks B,et al.Plasminogen activators in ectopic and uterine endometrium.Fertil Steril,1995,63(1):45～50.
  • 3Bruner KL,Matrisian LM,Rodgers WH,et al.Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice.J Clin Invest,1997,99(12):2851～2857.
  • 4Tomg PL,Mao TL,Chan WY.Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression.Gynecol,2004,92(2):559～567.
  • 5Nap AW,Dunselman GA,Goeij AF.Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrance model.Hum Repmd,2004,19(5):2180～2187.
  • 6Chamber AF,Matrsian LM.Changing views of the role of matrix metalloproteinasis.J NATI Cancer Institute,1997,17:1260～1267.
  • 7Jones JL,Walker RA.Control of matrix metalloproteinase activity in cancer.J Pathol,1997,183:377～379.
  • 8Sharpe-Timms KL,Zimmer RL,Jolliff WJ,et al.Gonadotropin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators,matrix metalloproteinases,and their inhibitors in rat models for adhesion formation and endometriosis:potential GnRH-a-regulated mechanisms reducing adhesion formation.Fertil Steril,1998,69(5):916～923.
  • 9易桂英,凌斌.剖宫产术后腹壁切口子宫内膜异位症9例分析[J].中国临床保健杂志,2007,10(5):499-500. 被引量：5
  • 10高宗侠,凌斌,吴大保,姚凤球,程志祥,肖敏,冯定庆,高婷,雷蕾.血清催乳激素与抗心磷脂抗体联合检测在子宫内膜异位症诊断中的应用[J].中国临床保健杂志,2007,10(5):449-450. 被引量：5

二级参考文献10

  • 1[1]Toshifumi M,Michiyoshi T,Hiroshi M,et al.Prolactin secretion in endometriotic patients[J].Obstet Gynecol,1997,72(1):89-92.
  • 2[2]Mori T,Nagasawa H.Mechanism of development of prolactin-induced adenomyosis in mice[J].Acta Anat,1983,116(1):46-54.
  • 3[3]Lima AP,Moura MD.Prolactin and cortisol levels in women with endometriosis[J].Braz J Med Biol Res,2006,39(8):1121-1127.
  • 4[4]Arumugam K.Prolactin levels in the peritoneal fluid of infertile patients with endometriosis[J].Med Sci Res,1990,18(3):591.
  • 5[5]Startseva NV.Clinical immunological aspects of genital endometriosis[J].Akush Ginekol,1980,3 (3):23-26.
  • 6[6]Dmowski WP,Rana N,Michalowska J,et al.The effect of endometriosis,its stage and activity,and of autoantibodies on in vitro fertilization and embryo transfer success rates[J].Fertil Steril,1995,63 (3):555-562.
  • 7[7]Abrao MS,Podgaec S.The use of biochemical markers in the diagnosis of pelvic endoetriosis[J].Hum Reprod,1997,12(1):2523-2527.
  • 8[2]郎景和.腹壁内异症[M]//妇科手术笔记(第二卷).北京:中国科技出版社,2004:108.
  • 9黄醒华.对剖宫产术的思考[J].中国实用妇科与产科杂志,2003,19(7):385-388. 被引量：892
  • 10黄维新,郑九生,汤一贞.剖宫产术后几种特殊并发症[J].中国实用妇科与产科杂志,2003,19(7):399-400. 被引量：35

共引文献8

同被引文献15

引证文献2

二级引证文献6

浙江临床医学
2011年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部